CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-31 | Ciaramella Giuseppe President & CSO | Grant or award | +20,000 | 115,962 | ||
| 2023-03-31 | Evans John M. CEO | Grant or award | +56,250 | 1,115,303 | ||
| 2023-03-31 | Evans John M. CEO | Option exercise | +13,850 | $7.22 | $100K | 1,129,153 |
| 2023-03-31 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) | −13,850 | 196,904 | ||
| 2023-03-31 | Simon Amy Chief Medical Officer | Grant or award | +20,000 | 85,129 | ||
| 2023-03-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award | +20,000 | 51,277 | ||
| 2023-03-30 | Bellon Christine Chief Legal Officer | Option exercise | +6,272 | $7.22 | $45K | 64,713 |
| 2023-03-30 | Bellon Christine Chief Legal Officer | Option exercise | +2,669 | $7.22 | $19K | 67,382 |
| 2023-03-30 | Bellon Christine Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −6,272 | 13,674 | ||
| 2023-03-30 | Bellon Christine Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −2,669 | 16,736 | ||
| 2023-03-06 | Evans John M. CEO | Other acquisition | +225 | 1,059,053 | ||
| 2023-01-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-01-31 | Ciaramella Giuseppe President & CSO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-01-31 | Evans John M. CEO | Grant or award · Stock Option (Right to Buy) | +112,500 | 112,500 | ||
| 2023-01-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-01-27 | Burrell Terry-Ann Chief Financial Officer | Option exercise | +36,152 | $13.68 | $495K | 67,429 |
| 2023-01-27 | Burrell Terry-Ann Chief Financial Officer | Sale | −36,152 | $45.08 | $1.6M | 31,277 |
| 2023-01-27 | Burrell Terry-Ann Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −36,152 | 185,565 | ||
| 2023-01-26 | Burrell Terry-Ann Chief Financial Officer | Option exercise | +1,102 | $13.68 | $15K | 32,379 |
| 2023-01-26 | Burrell Terry-Ann Chief Financial Officer | Sale | −1,102 | $45.16 | $50K | 31,277 |
Page 12 of 32 · 630 trades